ES2025668T3 - Forma de dosificacion de seudoefedrina. - Google Patents

Forma de dosificacion de seudoefedrina.

Info

Publication number
ES2025668T3
ES2025668T3 ES198787308180T ES87308180T ES2025668T3 ES 2025668 T3 ES2025668 T3 ES 2025668T3 ES 198787308180 T ES198787308180 T ES 198787308180T ES 87308180 T ES87308180 T ES 87308180T ES 2025668 T3 ES2025668 T3 ES 2025668T3
Authority
ES
Spain
Prior art keywords
compartment
dosage form
pseudoefedrine
wall
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787308180T
Other languages
English (en)
Inventor
Larry G. Hamel
Felix A. Landrau
George V. Guittard
Patrick S.-L. Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2025668T3 publication Critical patent/ES2025668T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A UNA FORMA DE DOSIFICACION (10) PARA LIBERAR PSEUDOEFEDRINA EN UN MEDIO DE EMPLEO, QUE ESTA FORMADA POR: A) UN COMPARTIMENTO, B) UNA CANTIDAD (16) PARA DOSIFICAR ENTRE 80 Y 200 MG DE PSEUDOEFEDRINA O UNA SAL SUYA TERAPEUTICAMENTE ACEPTABLE EN EL COMPARTIMENTO, C) UNA PARED (12) QUE TIENE, AL MENOS EN PARTE, UNA COMPOSICION A BASE DE ACETATO DE CELULOSA, TRIACETATO DE CELULOSA O HIDROXIPROPILCELULOSA, QUE ES PERMEABLE AL PASO DE UN FLUIDO EXTERNO, Y RODEA Y DEFINE AL COMPARTIMENTO D) POR LO MENOS UN CONDUSTO (13) EN LA PARED PARA CONECTAR EL COMPARTIMENTO (15) CON EL EXTERIOR DE LA FORMA DE DOSIFICACION. SE CARACTERIZA POR: E) UNA LAMINA (19) QUE CONTIENE DE 25 A 65 MG DE PSEUDOEFEDRINA O UNA SAL SUYA, EN DISPOSICION LAMINAR CN EL EXTERIOR DE LA PARED (12), DE FORMA QUE EN OPERACION LA FORMA DE DOSIFICACION LIBERA PSEUDOEFEDRINA INMEDIATAMENTE DESDE LA LAMINA Y A UNA VELOCIDAD DE DOSIFICACION PREESTABLECIDA POR UNIDAD DE TIEMPO A PARTIR DEL COMPARTIMENTO (15).
ES198787308180T 1987-01-28 1987-09-16 Forma de dosificacion de seudoefedrina. Expired - Lifetime ES2025668T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/007,879 US4801461A (en) 1987-01-28 1987-01-28 Pseudoephedrine dosage form

Publications (1)

Publication Number Publication Date
ES2025668T3 true ES2025668T3 (es) 1992-04-01

Family

ID=21728592

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787308180T Expired - Lifetime ES2025668T3 (es) 1987-01-28 1987-09-16 Forma de dosificacion de seudoefedrina.

Country Status (7)

Country Link
US (1) US4801461A (es)
EP (1) EP0279976B1 (es)
JP (1) JPH0825872B2 (es)
CA (1) CA1286229C (es)
DE (1) DE3774264D1 (es)
ES (1) ES2025668T3 (es)
MX (1) MX9203560A (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
GB8717168D0 (en) * 1987-07-21 1987-08-26 Roussel Lab Ltd Controlled-release device
US5028434A (en) * 1988-07-21 1991-07-02 Alza Corporation Method for administering nilvadipine for treating cardiovascular symptoms
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
JP2885858B2 (ja) * 1989-01-31 1999-04-26 イー・ペー・アー・インテルナチオナーレ・ファルマ・アゲンチュル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 有効物質の制御放出システムおよびその製造方法
EP0384646B1 (en) * 1989-02-16 1993-06-09 Btg International Limited Dispensing device
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
ES2053339T3 (es) * 1990-09-28 1994-07-16 Pfizer Dispositivo dispensador conteniendo un medio hidrofobo.
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
CA2079934C (en) * 1991-10-15 2002-09-03 Edward J. Roche Taste mask coatings for preparing chewable pharmaceutical tablets
US5736159A (en) * 1995-04-28 1998-04-07 Andrx Pharmaceuticals, Inc. Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
US6110498A (en) * 1996-10-25 2000-08-29 Shire Laboratories, Inc. Osmotic drug delivery system
US6361796B1 (en) * 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
CN1158071C (zh) * 1997-05-30 2004-07-21 渗透有限公司 多层渗透装置
AU772807B2 (en) * 1998-07-01 2004-05-06 Warner-Lambert Company Llc (-)-pseudoephedrine as a sympathomimetic drug
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
CA2419653A1 (en) * 2000-09-08 2002-03-14 Warner-Lambert Company Prevention of acute sinusitis and sinus attack
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US6838093B2 (en) 2001-06-01 2005-01-04 Shire Laboratories, Inc. System for osmotic delivery of pharmaceutically active agents
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
CN100408029C (zh) * 2001-09-28 2008-08-06 麦克内尔-Ppc股份有限公司 有镶嵌部分的组合剂型
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
JP4867128B2 (ja) * 2002-10-01 2012-02-01 大正製薬株式会社 経口鼻炎治療用組成物
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
NZ539915A (en) * 2002-12-11 2007-09-28 Pfizer Prod Inc Controlled-release of an active substance into a high fat environment
US8293799B2 (en) * 2003-12-29 2012-10-23 Osmotica Keresleedelmo és Szolgáltató KFT Osmotic device containing a venlafaxine salt and a salt having an ion in common
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US20060177507A1 (en) * 2003-05-22 2006-08-10 Joaquina Faour Controlled release device containing lercanidipine
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
JP4919801B2 (ja) * 2003-09-26 2012-04-18 アルザ・コーポレーシヨン 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法
NZ546183A (en) * 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
ATE504288T1 (de) * 2003-09-26 2011-04-15 Alza Corp Oros-push-stick für die kontrollierte abgabe von wirkstoffen
JP5563731B2 (ja) * 2003-09-26 2014-07-30 アルザ・コーポレーシヨン オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050129764A1 (en) * 2003-12-11 2005-06-16 Vergez Juan A. Osmotic device containing licofelone
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
BRPI1010511A2 (pt) * 2009-04-09 2019-04-09 Alkermes Pharma Ireland Limited composição, e, métodos para tratar um paciente que sofre de esquizofrenia, e para reduzir o risco de comportamento suicida recorrente em um paciente com esquizofrenia ou desordem esquizoafetiva
ES2569925T3 (es) * 2009-09-30 2016-05-13 Acura Pharmaceuticals, Inc. Métodos y composiciones de disuasión del abuso
BR112012013676A2 (pt) 2009-12-07 2016-04-19 Mcneil Ppc Inc revestimento por imersão parcial de formas de dosagem para liberação modificada
RU2673818C2 (ru) 2012-11-30 2018-11-30 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
US9642811B2 (en) 2014-03-26 2017-05-09 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
EP3258916A1 (en) 2015-02-20 2017-12-27 Osmotica Kereskedelmi ES Szolgaltato KFT Controlled release oral dosage form of gaba receptor agonist with enhanced pharmacokinetics
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
KR20200013170A (ko) * 2018-07-20 2020-02-06 주식회사 코아팜바이오 약물 방출 제어 구조를 포함하는 정제 및 3d 프린트 기술을 이용한 정제 제조방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3916399A (en) 1974-09-09 1975-10-28 Bell Telephone Labor Inc Rectifier monitoring circuit
US4038864A (en) 1974-10-15 1977-08-02 State Board Of Higher Education For And On Behalf Of The University Of Oregon Hydrocarbon measurement
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
DE2802114A1 (de) * 1978-01-19 1979-07-26 Sandoz Ag Neue pharmazeutische zusammensetzung und verfahren zu deren herstellung
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4576604A (en) 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4627971A (en) * 1985-04-22 1986-12-09 Alza Corporation Osmotic device with self-sealing passageway
US4662880A (en) * 1986-03-14 1987-05-05 Alza Corporation Pseudoephedrine, brompheniramine therapy

Also Published As

Publication number Publication date
JPS63258409A (ja) 1988-10-25
EP0279976A1 (en) 1988-08-31
CA1286229C (en) 1991-07-16
MX9203560A (es) 1992-09-30
EP0279976B1 (en) 1991-10-30
US4801461A (en) 1989-01-31
DE3774264D1 (de) 1991-12-05
JPH0825872B2 (ja) 1996-03-13

Similar Documents

Publication Publication Date Title
ES2025668T3 (es) Forma de dosificacion de seudoefedrina.
GB9727102D0 (en) Microparticles and their therapeutic use
OA03775A (fr) Casier à flotteur pour l'élevage ou le stockage des coquillages.
USD269851S (en) Retainer clip for pipes, rods and other elongated bodies or the like
ES2183023T3 (es) Composicion farmaceutica estabilizada con un agente basico.
DE3882631T2 (de) Waessrige dispersionen.
DE68910842D1 (de) Dispersionen aus Verbundpartikeln.
ES2125421T3 (es) Composicion de jabon solido y transparente, a base de sales de acidos grasos que contienen isoprenglicol.
DE3887323T2 (de) Durch elektroschmelzen hergestellte verbindung.
BE753736A (fr) Epurateur de l'air des locaux, eliminant les fumees, odeurs, poussieres, etc...
IT8841680A0 (it) Supporto particolarmente per iniezioni o prelievi.
CA981594A (en) Appareil pour la concentration d'un liquide contenant des elements non ultrafiltrables
IT8709375A0 (it) Organo destinato ad essere posizionato,con l'aiuto di un utensile quale una chiave,per spostamento assiale in un posto di accesso difficile del suo supporto.
DE69007791D1 (de) Zigarette mit verminderter seitenströmung des rauches.
ES493034A0 (es) Mejoras introducidas en el objeto de la patente principal n.459766:sobre sistema para herrar caballos.
IT8121966A0 (it) Sistema per intensificare la deflessione orizzontale in cinescopi.
FR2698545B1 (fr) Sirop contenant de la n-acetyl-cysteine.
USD287344S (en) Moose head trophy
USD268685S (en) Guitar head
USD268624S (en) Veterinarian vest
YU158490A (sh) Uređaj za suzbijanje potkornjaka, naročito drvotočca
USD270856S (en) Holding tank for a boat or the like
USD247003S (en) Hobby horse
JPS525971A (en) Excreta purifying tank
NO893925L (no) 1-metyl-3, 5, 7-triaza-1-azoniatricyklodekan trijodid, fremgangsmaate for fremstilling derav, og anvendelse derav ved bekjempelse av mikroorganismer i vandige systemer.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 279976

Country of ref document: ES